BI Academy: Digital Health Companies and Pharma – Uniting the Value Chains

New York BioLabs
180 Varick Street
5th Floor 
New York, NY

The role of digital health has been increasing significantly in the past few years. Technologies now span the value chain from R&D in pharma, to patient engagement, provider care, disease prevention, and cost-containment and health outcomes for payers. At the same time, the healthcare ecosystem is changing in ways that stresses the traditional pharma drug development and business model.

So, how will pharmas and digital health companies work together to overcome emerging hurdles to positively disrupt healthcare? What is still missing? What challenges keep these two value chains from fully merging and truly deliver efficient healthcare for the greater good for patients?

Come join us for a panel discussion with digital health and pharma experts on what each sector need to do to leverage each other’s strengths to improve patients’ lives.

Panel Chair:

Jeff Elton, PhD – Managing Director-Strategy, Life Sciences & Head Predictive Health Intelligence at Accenture

Panelists:

Savitri Basavaiah – Portfolio Marketing & Digital Lead, Pfizer Oncology

Larry Brooks, MBA – Vice President, Strategy – Evolution Road; former Director of Business Innovations, Digital Health – Boehringer Ingelheim

Carine Boustany, PhD – US Head, Cardiometabolic Diseases Research – Boehringer Ingelheim

Wasim Malik, PhD, MBA – Chief Digital Strategist; Roivant Sciences

Ya-El Mandel-Portnoy, PhD – Founder & CEO; Cardea Sciences